Conference Proceedings

Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521

Howard M Sandler, Theodore Karrison, A Oliver Sartor, Leonard G Gomella, Mahul B Amin, James Purdy, Jeff M Michalski, Mark Garzotto, Nadeem Pervez, Alexander G Balogh, George Rodrigues, Luis Souhami, M Neil Reaume, Scott Williams, Raquibul Hannan, Christopher U Jones, Eric M Horwitz, Joseph P Rodgers, Felix Y Feng, Seth A Rosenthal

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2020

Grants

Awarded by NCI


Funding Acknowledgements

U10CA180868 (NRG Operations), U10CA180822 (NRG SDMC), U24CA180803 (IROC) from the NCI and Sanofi-Synthelabo Int. Clinical trial information: NCT00288080.